Cardinal Health, Inc. $CAH Shares Bought by Franklin Resources Inc.

Franklin Resources Inc. boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 20.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 585,059 shares of the company’s stock after buying an additional 97,970 shares during the period. Franklin Resources Inc. owned approximately 0.25% of Cardinal Health worth $120,230,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Aventura Private Wealth LLC acquired a new position in Cardinal Health during the 4th quarter valued at about $25,000. Jones Financial Companies Lllp increased its position in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares in the last quarter. Palladiem LLC acquired a new position in Cardinal Health during the 4th quarter valued at about $28,000. JPL Wealth Management LLC acquired a new position in Cardinal Health during the 3rd quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in Cardinal Health during the 3rd quarter valued at about $31,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Up 1.5%

Shares of CAH opened at $215.77 on Thursday. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60. The company has a market capitalization of $50.54 billion, a price-to-earnings ratio of 32.99, a PEG ratio of 1.16 and a beta of 0.52. The stock’s 50-day moving average price is $202.77 and its 200-day moving average price is $208.66.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the prior year, the business earned $2.35 earnings per share. The company’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

Analysts Set New Price Targets

CAH has been the topic of a number of research reports. Robert W. Baird set a $248.00 price objective on Cardinal Health in a report on Friday, May 1st. JPMorgan Chase & Co. cut their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Citigroup cut their price objective on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a report on Friday, May 1st. William Blair initiated coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Finally, Morgan Stanley increased their price objective on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.